carmustine has been researched along with Carcinoma, Non-Small Cell Lung in 7 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Zakaria, MA | 1 |
| Rajab, NF | 1 |
| Chua, EW | 1 |
| Selvarajah, GT | 1 |
| Masre, SF | 1 |
| Hua, XM | 1 |
| Ren, XW | 1 |
| Liu, FL | 1 |
| Liu, Y | 1 |
| Zhang, CJ | 1 |
| Li, ZJ | 1 |
| Xu, L | 1 |
| Liu, JY | 1 |
| Liu, YG | 1 |
| Berhane, K | 1 |
| Hao, XY | 1 |
| Egyházi, S | 3 |
| Hansson, J | 3 |
| Ringborg, U | 3 |
| Mannervik, B | 2 |
| Shaw, GL | 1 |
| Gazdar, AF | 1 |
| Phelps, R | 1 |
| Steinberg, SM | 1 |
| Linnoila, RI | 1 |
| Johnson, BE | 1 |
| Oie, HK | 1 |
| Russell, EK | 1 |
| Ghosh, BC | 1 |
| Pass, HI | 1 |
| Minna, JD | 1 |
| Mulshine, JL | 1 |
| Ihde, DC | 1 |
| Edgren, MR | 1 |
| Kröckel, D | 1 |
| Bible, KC | 1 |
| Kaufmann, SH | 1 |
| Bergh, J | 1 |
| Karran, P | 1 |
2 trials available for carmustine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
[Comparision of high dose impulsion and low dose density chemotherapeutic regimens with paclitaxel plus cisplatin in advanced NSCLC].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-C | 2004 |
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cel | 1996 |
5 other studies available for carmustine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model.
Topics: Animals; Biomarkers, Tumor; Carcinogens; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; C | 2021 |
Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line.
Topics: Carcinoma, Non-Small-Cell Lung; Carmustine; DNA Repair; Drug Resistance; Enzyme-Linked Immunosorbent | 1993 |
Role of O6-methylguanine-DNA methyltransferase, glutathione transferase M3-3 and glutathione in resistance to carmustine in a human non-small cell lung cancer cell line.
Topics: Antineoplastic Agents, Alkylating; Carcinoma, Non-Small-Cell Lung; Carmustine; Dose-Response Relatio | 1997 |
Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carmustine; Cisplati | 1997 |
Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines.
Topics: Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carmustine; Cell Line; Cell Survival; DNA, Ne | 1991 |